The National Cancer Institute (NCI) is offering this grant to support the advanced development and validation of emerging molecular and cellular analysis technologies for cancer research. This grant aims to fund projects where novel technologies, having passed pilot stages and shown promise, require technical validation within appropriate cancer-relevant biological systems. The ultimate goal is to accelerate breakthroughs in cancer biology, treatment, diagnosis, prevention, control, epidemiology, and health disparities. Applicants must demonstrate established proof-of-principle and provide supportive preliminary data. This funding is specifically for technologies with the potential to yield a major impact across broad cancer research areas, not for applying established technologies to novel biological questions.
Opportunity ID: 135254
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-12-003 |
| Funding Opportunity Title: | Validation and Advanced Development of Emerging Technologies for Cancer Research (R33) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 21, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 18, 2012 |
| Current Closing Date for Applications: | Sep 18, 2012 |
| Archive Date: | Oct 19, 2012 |
| Estimated Total Program Funding: | $3,500,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses City or township governments County governments Special district governments Private institutions of higher education Small businesses State governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), solicits grant applications proposing research projects on the advanced development of emerging molecular and cellular analysis technologies through technical/analytical validation in an appropriate cancer-relevant biological system or context. An emerging technology is defined as one that has passed the pilot developmental stage and shows promise, but has not yet been evaluated within the context of its intended use. If successful, these technologies would accelerate research in cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. This FOA solicits projects where proof-of-principle of the proposed technology or methodology has been established and supportive preliminary data are available. Projects proposed to this FOA should reflect the potential to produce a major impact in a broad area of cancer-relevant research. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this solicitation as non-responsive and will not be reviewed. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-003.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B2 | ADOBE-FORMS-B2 | PKG00089373 | Jan 23, 2012 | Sep 18, 2012 | View |
Package 1
Mandatory forms
135254 RR_SF424_1_2-1.2.pdf
135254 PerformanceSite_1_4-1.4.pdf
135254 RR_OtherProjectInfo_1_3-1.3.pdf
135254 RR_KeyPersonExpanded_1_2-1.2.pdf
135254 RR_Budget-1.1.pdf
135254 PHS398_CoverPageSupplement_1_4-1.4.pdf
135254 PHS398_ResearchPlan_1_3-1.3.pdf
135254 PHS398_Checklist_1_3-1.3.pdf
Optional forms
135254 RR_SubawardBudget30-1.2.pdf
135254 PHS_CoverLetter_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
